Ohio Clinical Trial Tests Probiotics to Help Ovarian Cancer Patients Tolerate Chemotherapy

A new clinical trial at the Ohio State University Comprehensive Cancer Center is testing whether probiotics can help ovarian cancer patients better tolerate chemotherapy. The results matter to patients experiencing treatment side effects, as the trial is examining the role of gut health in this tolerance.

AI-written summary of 2 sources; every verified point is backed by a verbatim quote. How Iyan works

• The clinical trial is being conducted at the Ohio State University Comprehensive Cancer Center, known as OSUCCC – James.

  «A new clinical trial at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital»

  Newswise
• The trial is testing whether probiotics help ovarian cancer patients better tolerate chemotherapy.

  «is testing whether probiotics can help patients with ovarian cancer better tolerate chemotherapy»

  Newswise • EurekAlert!
• The news was published under nearly the same headline on EurekAlert! on the same day.

  «Can better gut health help patients with ovarian cancer tolerate chemotherapy?»

  EurekAlert!

Iyan — See it for yourself. What changed in your world today, why it matters, and how we know.
How it works • Privacy • Terms